AbbVie hep C drug gets priority review in Japan
April 16, 2015Sales and Marketing AbbVie, EC, EU, Europe, Exviera, FDA, Japan, Viekira Pak, Viekirax, hepatitis C, ombitasvir/paritaprevir/ritonavir
AbbVie’s combination hepatitis C treatment looks set to be approved in yet another country after being granted priority review in …
Sun Pharma and Technion form oncology research pact
April 16, 2015Research and Development, Sales and Marketing Cancer, Sun Pharma, institute of technology, oncology, technion
Mumbai-based Sun Pharmaceuticals Industries is teaming up with the Israel Institute of Technology Technion to develop new oncology drugs. This …
New managing director for PM Devereux
April 16, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Julian Seward, PM Devereux
Healthcare, science and technology architectural firm PM Devereux has confirmed the appointment of Julian Seward as a managing director. Seward …
Pfizer breast cancer trial stopped following promising results
April 15, 2015Sales and Marketing ASCO, FDA, Pfizer, ibrance, palbociclib
Regulators have stopped a Phase III clinical trial of Pfizer’s Ibrance early after it demonstrated improved survival in women with …
Trial results back NICE decision on Novartis cancer drug
April 15, 2015Sales and Marketing Arzerra, Cancer, NHS, NICE, chemo, chlorambucil, fludarabine, leukaemia, ofatumumab
Treatment with Arzerra improves survival in people with chronic lymphocytic leukaemia (CLL) according to study results that back NICE’s decision …
Merck hires life sciences business head
April 15, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Merck, Merck Millipore, Sigma-Aldrich, udit batra
Merck has confirmed that the current chief executive and president of Merck Millipore Dr Udit Batra has been appointed to lead …
FDA grants AstraZeneca immune drug orphan status
April 15, 2015Sales and Marketing AstraZeneca, FDA, Iressa, MEDI4736, MedImmune, NSCLC, US, gefitinib, non-small cell lung cancer, tremelimumab
The US Food and Drug Administration has granted orphan drug designation to AstraZeneca’s anti-CTLA-4 monoclonal antibody tremelimumab for the treatment …
AZ and Takeda diabetes drugs get FDA safety update
April 15, 2015Manufacturing and Production, Sales and Marketing AstraZeneca, FDA, Nesina, Onglyza, Takeda, alogliptin, cardiovascular, diabetes, saxagliptin
An FDA advisory committee has said that the labels of two type 2 diabetes drugs should be changed to warn …
J&J strong pharma sales can’t offset Q1 losses
April 15, 2015Sales and Marketing J&J, JJ, Q1, Waldenström's macroglobulinemia, Waldenström’s Macroglobulinemia, Zytiga, abiraterone acetate, financials, ibrutinib, imbruvica
Johnson & Johnson’s pharma division achieved worldwide sales of $7.7 billion in the first quarter of this year – but …
Vetter confirms new managing director
April 15, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Oliver Albrecht, Vetter
German contract development and manufacturing organisation Vetter has appointed Oliver Albrecht as a managing director. Albrecht replaces Max Horn in …
World Health Organisation calls for full trial transparency
April 14, 2015Research and Development, Sales and Marketing Ben Goldacre, EU, WHO, World Health Organisation, alltrials, clinical trials, sense about science, transparency
The World Health Organization has thrown its weight behind clinical trial transparency in a new statement on its position. WHO …
IBM partners with J&J, Apple and Medtronics ‘to transform healthcare’
April 14, 2015Sales and Marketing Apple, J&J, JJ, ibm, medtronics
IT firm IBM has teamed up with pharma giants and tech companies to expand its presence in the health and …
AstraZeneca partners with PatientsLikeMe
April 14, 2015Sales and Marketing AstraZeneca, Lupus, PatientsLikeMe, Roche, diabetes, oncology, respiratory disease
AstraZeneca has signed a five-year agreement with PatientsLikeMe to give the pharma firm access to the latter’s global network of …
Sanofi rules out Toujeo discount in diabetes
April 14, 2015Sales and Marketing 100 U/mL, Boehringer, Lantus, insulin glargine [rDNA origin] injection, lilly, toujeo
Sanofi has revealed that it will not discount its new insulin Toujeo more than its current blockbuster Lantus, despite lacking …
US drug spend soars to all-time high in 2014
April 14, 2015Manufacturing and Production, Sales and Marketing Lipitor, Obama, UK Health and Social Care Information Centre, US, drug spend, prescribing
The number of prescriptions dispensed in the US rose by 13% in 2014 a new report has shown. The increase …
Manufacturing woes hit Baxter again
April 14, 2015Manufacturing and Production, Sales and Marketing FDA, Gemünden, Pfizer, alesse, baxter, manufacturing, recall, vectura group
Baxter is voluntarily recalling several lots of intravenous solutions due to the potential presence of particulate matter. The news has …
Ashfield Healthcare names new UK managing director
April 14, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ashfield, colin watson
Ashfield Healthcare has appointed Colin Watson as its managing director for the UK, taking over from Enda Scott who has …
Cancer Research Technology and Medivir to develop new class of cancer drugs
April 13, 2015Research and Development, Sales and Marketing Medivir, UK, adam8, cancer research technology, oncology
Cancer Research Technology and Medivir will join forces to develop a new class of drugs that has shown promise for …
Most anticipated health wearable lands shortly
April 13, 2015Medical Communications, Sales and Marketing Apple, digital, research kit, smartwatch, watch, wearable, wearables
Consumers can order Apple’s eagerly anticipated watch now as the industry waits to see just what impact it could have …
Novartis to highlight Gilenya data at neurology congress
April 13, 2015Sales and Marketing American Academy of Neurology, Novartis, fingolimod, gilenya
Novartis will be highlighting data for its multiple sclerosis drug Gilenya at this year’s American Academy of Neurology (AAN) annual …
Latest content
Migraine annual economic and quality-of-life burden in UK
bit.bio expands human heart cell portfolio through myriamed partnership
Phoenix Labs acquires Kent Pharma
Astoriom acquires Sampled’s UK stability storage operations
